Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating DNA: Diagnostic Tool and Predictive Marker for Overall Survival of NSCLC Patients

12 Jun 2012

Abstract excerpt

PURPOSE: The purpose of our study was to determine whether the amounts of circulating DNA (cDNA) could discriminate between NSCLC patients and healthy individuals and assess its value as a prognostic marker of this disease. METHODS: We conducted a study of 309 individuals and the cDNA levels were assessed through real-time PCR methodology. RESULTS: We found increased cDNA levels in NSCLC patients compared to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Genetic factors in colorectal cancer
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22701665
DOI: 10.1371/journal.pone.0038559

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating DNA: Diagnostic Tool and Predictive Marker for Overall Survival of NSCLC PatientsPMID 22701665Read ↗

Comparison of Circulating Plasma DNA Levels between Lung Cancer Patients and Healthy ControlsSemantic proximity Read ↗

Role of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancer.Semantic proximity Read ↗

Circulating DNA and lung cancer.Semantic proximity Read ↗

Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancerSemantic proximity Read ↗

The prognostic role of circulating DNA markers in patients with lung malignancies: a systematic review and meta-analysis.Semantic proximity Read ↗

Quantification of concentration and assessment of EGFR mutation in circulating DNA.Semantic proximity Read ↗

Circulating Cell-Free DNA in Plasma/Serum of Lung Cancer Patients as a Potential Screening and Prognostic ToolSemantic proximity Read ↗

Quantitative Analysis of Circulating Plasma DNA as a Tumor Marker in Thoracic MalignanciesSemantic proximity Read ↗

Comparison of circulating DNA from plasma and urine for EGFR mutations in NSCLC patients.Semantic proximity Read ↗

Quantification of Free Circulating DNA As a Diagnostic Marker in Lung CancerSemantic proximity Read ↗

Circulating cell-free DNA in plasma of never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy.Semantic proximity Read ↗

Clinical significance of pretreatment plasma biomarkers in advanced non-small cell lung cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.